Inhibitors of the e2f-1/cyclin interaction for cancer therapy
CA 2432031 A1 · Owner: Chen, Ying-Nan Pan · Inventors: Ramsey, Timothy Michael; Sabio, Michael Lloyd; Sharma, Sushil Kumar
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The novel compounds of this invention have the general structural formula lad: The compounds of this invention relate to 8-mer 7-mer, 6-mer and 5-mer , peptides having the following amino acid sequences and referred to , collectively as having "formula la-d": or a pharmaceutically acceptable salt or ester thereof, that inhibit the interaction of the transcription factor E2F- 1 to Cyclin A. As an antagonist of the E2F-1/Cyclin A interaction the , compounds of the present invention may be used in the treatment of cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 19, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.